Opportunity of a lifetime imho
dyor
- Forums
- ASX - By Stock
- NEU
- Ann: Q3 2021 quarterly activity and cash flow report
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.54%
!
$12.92

Ann: Q3 2021 quarterly activity and cash flow report, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.92 |
Change
0.070(0.54%) |
Mkt cap ! $1.626B |
Open | High | Low | Value | Volume |
$13.15 | $13.37 | $12.91 | $6.366M | 485.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 2087 | $12.91 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.92 | 2433 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 143 | 12.940 |
4 | 765 | 12.930 |
7 | 2516 | 12.920 |
6 | 1929 | 12.910 |
9 | 3740 | 12.900 |
Price($) | Vol. | No. |
---|---|---|
12.950 | 2905 | 14 |
12.960 | 1219 | 15 |
12.970 | 1019 | 7 |
12.980 | 2414 | 10 |
12.990 | 2796 | 11 |
Last trade - 15.37pm 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online